BackgroundResearch and innovation (R&I) in healthcare are often shaped by academic and funding actors, risking research-agenda bias—where pressing societal needs remain under-addressed. Inclusive consultation may help align innovation with real-world challenges.ObjectiveThis study empirically investigates the potential effects of research-agenda bias on system innovation by comparing perspectives from academic, business, governmental, and societal stakeholders to explore uniquely identified challenges surrounding the care and support for rheumatic diseases and the opportunities to improve them.MethodsWe conducted a qualitative study of a multi-stakeholder consultation commissioned by the Dutch Arthritis Society. A total of 141 stakeholders—patients, healthcare professionals, researchers, business representatives, and government actors—were consulted via interviews, focus groups, and an online workshop. Reflexive thematic analysis was used to identify stakeholder-defined challenges and opportunities, inductively clustered into thematic areas.ResultsFive clusters of challenges emerged: 1) physical complaints, 2) consequential challenges of chronic disease (e.g. daily functioning, mental health, work), 3) managing disease, including treatment and coordination, 4) causes of disease progression, and 5) systemic barriers. Academic and business stakeholders focused on biomedical and systemic innovation; societal stakeholders uniquely addressed psychosocial and practical challenges. Opportunities were unevenly distributed, with relatively few targeting societal issues.ConclusionBroad stakeholder consultation reveals overlooked challenges and supports the development of a transformative action agenda. Structurally embedding diverse perspectives into agenda-setting helps align innovation strategies with real-world needs and supports socially robust, system-level change.